Status: Recruiting
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
This trial represents a single institution phase I/II pilot study with the primary objective of establishing the safety and feasibility of generating and infusing ML NK cells after TCRαβ haplo-HCT.
Participants needed: 68
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Washington University School of MedicineUpdated: May 5, 2026Locations: 1
Eligibility criteria
Complete remission (CR) defined by < 5% marrow blasts by morphology in the conte... [+42]
Both Cohorts [+20]